These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35014603)

  • 1. Beyond bispecificity: Controlled Fab arm exchange for the generation of antibodies with multiple specificities.
    Yanakieva D; Pekar L; Evers A; Fleischer M; Keller S; Mueller-Pompalla D; Toleikis L; Kolmar H; Zielonka S; Krah S
    MAbs; 2022; 14(1):2018960. PubMed ID: 35014603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic assessment of SEED: a new engineered antibody platform designed to generate mono- and bispecific antibodies.
    Muda M; Gross AW; Dawson JP; He C; Kurosawa E; Schweickhardt R; Dugas M; Soloviev M; Bernhardt A; Fischer D; Wesolowski JS; Kelton C; Neuteboom B; Hock B
    Protein Eng Des Sel; 2011 May; 24(5):447-54. PubMed ID: 21498564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel efficient bispecific antibody format, combining a conventional antigen-binding fragment with a single domain antibody, avoids potential heavy-light chain mis-pairing.
    Huang S; Segués A; Hulsik DL; Zaiss DM; Sijts AJAM; van Duijnhoven SMJ; van Elsas A
    J Immunol Methods; 2020 Aug; 483():112811. PubMed ID: 32569598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteine-SILAC Mass Spectrometry Enabling the Identification and Quantitation of Scrambled Interchain Disulfide Bonds: Preservation of Native Heavy-Light Chain Pairing in Bispecific IgGs Generated by Controlled Fab-arm Exchange.
    van den Bremer ETJ; Labrijn AF; van den Boogaard R; Priem P; Scheffler K; Melis JPM; Schuurman J; Parren PWHI; de Jong RN
    Anal Chem; 2017 Oct; 89(20):10873-10882. PubMed ID: 28922593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled Fab-arm exchange for the generation of stable bispecific IgG1.
    Labrijn AF; Meesters JI; Priem P; de Jong RN; van den Bremer ET; van Kampen MD; Gerritsen AF; Schuurman J; Parren PW
    Nat Protoc; 2014 Oct; 9(10):2450-63. PubMed ID: 25255089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new model for intermediate molecular weight recombinant bispecific and trispecific antibodies by efficient heterodimerization of single chain variable domains through fusion to a Fab-chain.
    Schoonjans R; Willems A; Schoonooghe S; Leoen J; Grooten J; Mertens N
    Biomol Eng; 2001 Jun; 17(6):193-202. PubMed ID: 11337278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The eIg technology to generate Ig-like bispecific antibodies.
    Kühl L; Aschmoneit N; Kontermann RE; Seifert O
    MAbs; 2022; 14(1):2063043. PubMed ID: 35427197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biophysical and biochemical characterization of a VHH-based IgG-like bi- and trispecific antibody platform.
    Pekar L; Busch M; Valldorf B; Hinz SC; Toleikis L; Krah S; Zielonka S
    MAbs; 2020; 12(1):1812210. PubMed ID: 32887531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mabfilin and Fabfilin - New antibody-scaffold fusion formats for multispecific targeting concepts.
    Kahl M; Settele F; Knick P; Haupts U; Bosse-Doenecke E
    Protein Expr Purif; 2018 Sep; 149():51-65. PubMed ID: 29704557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of CrossMAb technology for the generation of bi- and multispecific antibodies.
    Klein C; Schaefer W; Regula JT
    MAbs; 2016; 8(6):1010-20. PubMed ID: 27285945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface.
    Lewis SM; Wu X; Pustilnik A; Sereno A; Huang F; Rick HL; Guntas G; Leaver-Fay A; Smith EM; Ho C; Hansen-Estruch C; Chamberlain AK; Truhlar SM; Conner EM; Atwell S; Kuhlman B; Demarest SJ
    Nat Biotechnol; 2014 Feb; 32(2):191-8. PubMed ID: 24463572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grabbing the Bull by Both Horns: Bovine Ultralong CDR-H3 Paratopes Enable Engineering of 'Almost Natural' Common Light Chain Bispecific Antibodies Suitable For Effector Cell Redirection.
    Klewinghaus D; Pekar L; Arras P; Krah S; Valldorf B; Kolmar H; Zielonka S
    Front Immunol; 2021; 12():801368. PubMed ID: 35087526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange.
    Labrijn AF; Meesters JI; de Goeij BE; van den Bremer ET; Neijssen J; van Kampen MD; Strumane K; Verploegen S; Kundu A; Gramer MJ; van Berkel PH; van de Winkel JG; Schuurman J; Parren PW
    Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5145-50. PubMed ID: 23479652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An efficient process of generating bispecific antibodies via controlled Fab-arm exchange using culture supernatants.
    Paul S; Connor J; Nesspor T; Haytko P; Boakye K; Chiu ML; Jiang H
    Protein Expr Purif; 2016 May; 121():133-40. PubMed ID: 26826313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity Maturation of B7-H6 Translates into Enhanced NK Cell-Mediated Tumor Cell Lysis and Improved Proinflammatory Cytokine Release of Bispecific Immunoligands via NKp30 Engagement.
    Pekar L; Klausz K; Busch M; Valldorf B; Kolmar H; Wesch D; Oberg HH; Krohn S; Boje AS; Gehlert CL; Toleikis L; Krah S; Gupta T; Rabinovich B; Zielonka S; Peipp M
    J Immunol; 2021 Jan; 206(1):225-236. PubMed ID: 33268483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel CH1:CL interfaces that enhance correct light chain pairing in heterodimeric bispecific antibodies.
    Bönisch M; Sellmann C; Maresch D; Halbig C; Becker S; Toleikis L; Hock B; Rüker F
    Protein Eng Des Sel; 2017 Sep; 30(9):685-696. PubMed ID: 28981885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constant domain-exchanged Fab enables specific light chain pairing in heterodimeric bispecific SEED-antibodies.
    Dietrich S; Gross AW; Becker S; Hock B; Stadlmayr G; Rüker F; Wozniak-Knopp G
    Biochim Biophys Acta Proteins Proteom; 2020 Jan; 1868(1):140250. PubMed ID: 31295556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward Drug-Like Multispecific Antibodies by Design.
    Sawant MS; Streu CN; Wu L; Tessier PM
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering Bifunctional Antibodies with Constant Region Fusion Architectures.
    Du J; Cao Y; Liu Y; Wang Y; Zhang Y; Fu G; Zhang Y; Lu L; Luo X; Kim CH; Schultz PG; Wang F
    J Am Chem Soc; 2017 Dec; 139(51):18607-18615. PubMed ID: 29186655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramolecular trimerization, a novel strategy for making multispecific antibodies with controlled orientation of the antigen binding domains.
    Alvarez-Cienfuegos A; Nuñez-Prado N; Compte M; Cuesta AM; Blanco-Toribio A; Harwood SL; Villate M; Merino N; Bonet J; Navarro R; Muñoz-Briones C; Sørensen KM; Mølgaard K; Oliva B; Sanz L; Blanco FJ; Alvarez-Vallina L
    Sci Rep; 2016 Jun; 6():28643. PubMed ID: 27345490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.